Zydus Lifesciences’ Verapamil Approval Analyzed

Zydus Lifesciences has just gotten the “okay” from the US Food and Drug Administration (FDA) to sell Verapamil tablets. These tablets help people lower their high blood pressure. Lowering high blood pressure is important because it reduces the chance of having serious problems like strokes or heart attacks.

• Zydus received FDA approval for Verapamil tablets.
• Tablets lower high blood pressure effectively.
• Reduced risk of strokes and heart attacks.
• Production in Baddi, Himachal Pradesh, India.
• Significant sales: $24.5 million in the U.S.
• Expanding access to a crucial cardiovascular treatment.

The Verapamil tablets come in three strengths: 120 mg, 180 mg, and 240 mg. They’re made at Zydus Lifesciences’ factory in Baddi, Himachal Pradesh, India. The FDA’s approval means that Zydus can now sell these tablets in the United States.

Zydus already sells a lot of these tablets. In the nine months leading up to September 2025, they sold $24.5 million worth of Verapamil tablets in the U.S. This shows a strong market demand for this medication.

This approval is a positive step for Zydus Lifesciences and for people who need to manage their blood pressure. It adds another important medicine to their portfolio.

This FDA approval validates Zydus’ commitment to providing effective cardiovascular solutions.